Intermune (ITMN) was upgraded by UBS (UBS) to neutral from neutral to buy with a price target of $15, as factors that were holding down the stock price are no longer an issue. Shares are higher by about 4.8 percent.
Intermune (ITMN) was upgraded by UBS (UBS) to neutral from neutral to buy with a price target of $15, as factors that were holding down the stock price are no longer an issue. Shares are higher by about 4.8 percent.
